Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials
- 1 August 1987
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 102 (1) , 127-141
- https://doi.org/10.1016/s0022-1759(87)80018-2
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Large scale production of human lymphokine activated killer cells for use in adoptive immunotherapyJournal of Immunological Methods, 1986
- Functional characterization of T lymphocytes propagated from human lung carcinomasClinical Immunology and Immunopathology, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to the immunotherapy of human cancerCancer, 1985
- Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2Science, 1984
- Specific and non-specific lymphocyte cytotoxicity in colon carcinomaBritish Journal of Cancer, 1981
- In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors.The Journal of Immunology, 1980
- Immunoreactivity by intrinsic lymphoid cells in colorectal carcinomaBritish Journal of Cancer, 1979
- Activated T lymphocytes within human solid tumorsCancer Immunology, Immunotherapy, 1979